Question 1

What is Sonoma Pharmaceuticals?

Accepted Answer

Sonoma Pharmaceuticals is a Company.

Question 2

How often does Sonoma Pharmaceuticals appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Sonoma Pharmaceuticals first tracked by Ergen?

Accepted Answer

First tracked on Apr 24, 2026.

Question 4

When was Sonoma Pharmaceuticals last mentioned in news?

Accepted Answer

Last active on Jun 30, 2026.

Question 5

What is Sonoma Pharmaceuticals's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Sonoma Pharmaceuticals in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Sonoma Pharmaceuticals?

Accepted Answer

Sonoma Pharmaceuticals gets FDA clearance (Jun 30, 2026, 6 articles).

Question 8

How did the "Sonoma Pharmaceuticals gets FDA clearance" event impact Sonoma Pharmaceuticals?

Accepted Answer

Sonoma Pharmaceuticals received FDA 510(k) clearance for its Microdacyn Wound Irrigation Solution, expanding its market opportunities and strengthening its wound care portfolio. This approval is a significant competitive advantage and supports its long-term growth strategy.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.